Search
for
Sort by
Research 931–960 of 1000+
- The Evaluation and Management of Hirsutism
- Cellular actions of testosterone in vascular cells: Mechanism independent of aromatization to estradiol
- The control of hair growth.
- Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia
- The Hirsute Woman: Challenges in Evaluation and Management
- The antiandrogens. When and how they should be used.
- [Cutaneous effects in hormonal contraception].
- Hirsutism in Children: A Comprehensive Review of Etiology, Clinical Evaluation and Contemporary Management
- Androgenic Alopecia: Cross-Talk Between Cell Signal Transduction Pathways
- Inflammatory Phenomena and Fibrosis in Androgenetic Alopecia
- Hormone und Behaarung
- Who Tells the Story of the Treatment of Androgenetic Alopecia?—A Bibliometric Analysis From 2003 to 2023
- Pathogenesis of androgenetic alopecia
- Fundamentals
- SnapshotDx Quiz: August 2016
- Disorders of the pilosebaceous unit: hirsutism and androgenic alopecia
- Androgenetic alopecia
- Baicalin inhibits recruitment of GATA1 to the HSD3B2 promoter and reverses hyperandrogenism of PCOS
- Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster
- Association of androgenetic alopecia with a more severe form of COVID-19 infection
- Pathophysiology of Androgenetic Alopecia and Implications for Treatment: An Overview of Current Literature
- The role of testosterone in SARS-CoV-2 infection
- New developments in our understanding of acne pathogenesis and treatment
- Role of insulin, insulin‐like growth factor‐1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris
- The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea.
- Nutrition and acne
- Characteristics of Androgenetic Alopecia in Asian
- Clinical biochemistry of dihydrotestosterone
- Female pattern hair loss: current treatment concepts.
- Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial